Articles

PCSK9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Randomized, Double- Blind, Placebo-Controlled, Multicenter SHAWN Study

Wu ZM, Kan J, Ye F, et al.

Journal: 

Am Heart J

First published: June 26, 2024  DOI: 10.1016/j.ahj.2024.06.004

Abstract


Full Article